FDA-approved study uses adipose stem cells for treatment of shoulder injuries

January 19, 2017
Sanford Health is conducting the first clinical trial approved by the FDA to treat injured shoulders using patients’ adipose stem cells…

FDA NewsPerspective

FDA issues draft guidance on biosimilar interchangeability

January 18, 2017
The FDA has released a draft guidance for industry outlining criteria for demonstrating that a biosimilar is interchangeable with a reference product…

FDA News

FDA guidance recommends distinct names, suffixes for biosimilars

January 17, 2017
The FDA has released its final guidance for the naming of biological products, which recommends distinct names and suffixes for both biosimilars and…

Lipogems announces FDA clearance related to its system for adipose tissue transfer

December 4, 2016
Lipogems announced it has received an FDA 510(k) clearance for expanded indications and labelling of its Lipogems System for adipose tissue…

ACR asks for FDA guidelines on biosimilar substitution

October 21, 2016
During a public meeting on the reauthorization of the Biosimilar User Free Act, Angus Worthing, MD, FACR, FACP, incoming chair of the American…

In the Journals

Addition of diacerein to glucosamine therapy did not improve outcomes for OA

October 21, 2016
In a study of 148 patients with mild to moderate osteoarthritis of the knee, combination therapy of glucosamine plus diacerein did not improve pain…

Isto and Arteriocyte form new biologics company

October 20, 2016
Isto Holdings, the parent company of Isto Technologies, announced it has acquired Arteriocyte Medical Systems Inc. and will integrate the companies…

In the Journals

Arthroscopic rotator cuff repair augmented with collagen implant had biocompatibility at 6 months

October 16, 2016
Patients who underwent arthroscopic rotator cuff repair augmented with a collagen implant overlay had cellular incorporation, tissue formation and…

Bone marrow concentrate injections considered safe treatment of orthopedic injuries

Orthopedics Today, October 2016
Patients who received bone marrow concentrate injections alone experienced the lowest rate of adverse events, according to study results…

Meeting News CoverageFrom OT Europe

Speaker: Adjuvants may help resolve nonunions after failed bone grafting

September 16, 2016
BELFAST, NORTHERN IRELAND — A presenter at the British Orthopaedic Association Annual Congress, here, said orthopaedic surgeons should…

In the JournalsFrom OT Europe

Both local PRP and corticosteroid injections found effective for chronic plantar fasciitis

June 9, 2016
Patients with chronic plantar fasciitis can be effectively treated with local injection of platelet-rich plasma or corticosteroid, according to…

Bone Solutions Inc receives $1.7 million in funding

June 5, 2016
Bone Solutions Inc. announced it has surpassed its goal by achieving a funding round totaling more than $1.7 million after officially closing its…

From OT Europe

Tecres and Keensight partner to create Demetra Holding, an independent cement and biomaterials company

June 4, 2016
Tecres, a medical technology company that develops bone cements and bone substitutes, and Keensight Capital, a European growth private equity firm…

Cover StoryFrom OT Europe

Triage, teamwork lessons learned from earthquakes, tsunamis and terrorist attacks

Orthopaedics Today Europe, May 2016
Within minutes or days of a mass trauma event, hundreds — possibly thousands — of patients may arrive at the emergency room of a hospital…

In the Journals

Synovial fluid biomarkers may predict clinical outcomes after knee arthroscopy

May 18, 2016
Before patients undergo knee arthroscopy, synovial fluid biomarkers can reflect the intra-articular environment and potentially predict postoperative…

Meeting News CoverageFrom OT Europe

Early trial results show it may be possible to treat cartilage defects with MSCs

May 5, 2016
BARCELONA, Spain — At the European Society of Sports Traumatology, Knee Surgery & Arthroscopy Congress, investigators from Belarus reported…

From OT Europe

Despite complication risks, allograft reconstruction can manage defects

Orthopaedics Today Europe, March 2016
An allograft reconstruction for skeletally immature pediatric patients with malignant bone tumors may have a high rate of complications, but can…

From OT Europe

Anika Therapeutics obtains CE mark for Cingal to treat OA knee pain

Orthopaedics Today Europe, March 2016
Anika Therapeutics Inc. announced it has received CE mark approval for Cingal, reportedly the first and only commercially available combination…

From OT Europe

Anika Therapeutics obtains CE mark for Cingal to treat OA knee pain

March 28, 2016
Anika Therapeutics Inc. announced it has received CE mark approval for Cingal, reportedly the first and only commercially available combination…

AlloSource announces launch of 3-D fresh cartilage allograft to help with cartilage regeneration

March 27, 2016
AlloSource announced the launch of its ProChondrix Cartilage Restoration Matrix, a cellular 3-D fresh cartilage allograft. According to the company…